BackNLS Pharmaceutics Ltd - Warrants (25/09/2025) Overview

NLS Pharmaceutics Ltd - Warrants (25/09/2025) Current Cash

Latest current cash for NLSPW: $3.1M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.07M
455.83% YoYΔ $2.52M vs prior year quarter

Peer trimmed avg / median

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) Current Cash History

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) vs. peers: Current Cash Comparison

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) (NLSPW) FAQ

NLS Pharmaceutics Ltd - Warrants (25/09/2025) (NLSPW) currently reports a current cash of $3.1M as of June 2025. That compares with $550K in the prior-year period — up 455.8% year over year. Use the charts on this page to explore NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s current cash history and peer comparisons.

NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s current cash increased from $550K to $3.1M — a 455.8% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NLS Pharmaceutics Ltd - Warrants (25/09/2025) reported $3.1M in current cash as of June 2025. That compares with $550K in the prior-year period — up 455.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $3.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NLS Pharmaceutics Ltd - Warrants (25/09/2025), and consider following NLSPW for alerts when major investors trade the stock.

NLS Pharmaceutics Ltd - Warrants (25/09/2025) is classified in the Healthcare sector. On current cash, it currently shows $3.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NLSPW with unrelated industries.